DNA-Encoded Library Market, By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Autoimmune Diseases, and Metabolic Diseases), By Application, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4050
|
Published Date
June 2025
|
Pages
389
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
DNA-Encoded Library Market size was valued at US$ 766 Million in 2024, expanding at a CAGR of 13.5% from 2025 to 2032.
DNA-Encoded Libraries (DELs) represent a groundbreaking advancement in drug discovery, transforming how novel small molecule compounds are identified in the pharmaceutical industry. DELs are vast chemical libraries containing billions of unique small molecules, each covalently linked to a distinctive DNA barcode. This DNA barcode acts as a molecular identifier, encoding detailed information about the specific molecule and its synthesis history. The core advantage of DELs lies in their ability to screen an exceptionally large and diverse range of chemical structures—thousands of times greater than traditional compound libraries—significantly accelerating the drug discovery process.
DNA-Encoded Library Market- Market Dynamics
The DNA-Encoded Library (DEL) market is experiencing rapid growth, driven primarily by the pharmaceutical and biopharmaceutical industries’ demand for novel and efficient drug discovery solutions. The rising prevalence of chronic and complex diseases—including various cancers, neurodegenerative disorders, and infectious diseases—has accelerated the need for faster identification of potential therapeutic candidates. DEL technology offers a significant advantage by enabling the simultaneous screening of billions of compounds, thereby increasing the speed and efficiency of drug candidate discovery compared to traditional methods.
Recent advancements in molecular biology, genomics, and next-generation sequencing (NGS) have highlighted the immense potential of DEL platforms, fueling their evolution into a more powerful and widely adopted tool. Market expansion is further supported by growing strategic collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations (CROs), aimed at leveraging DEL expertise and infrastructure. Additionally, with global pharmaceutical R&D investment projected to exceed $200 billion annually by 2028, and governments worldwide increasing funding for advanced drug discovery technologies—reportedly investing over $15 billion in such innovations in 2023 alone—the DEL market is poised for substantial growth. However, the complexity of managing and analyzing the massive datasets generated by DEL screening presents challenges. The need for advanced computational tools and specialized bioinformatics talent may hinder technology adoption, particularly for small and mid-sized companies that lack these resources.
DNA-Encoded Library Market- Segmentation Analysis:
The Global DNA-Encoded Library Market is segmented on the basis of Therapeutic Area, Application, End Use, and Region.
The global DNA-encoded library (DEL) market, segmented by therapeutic area, is led by oncology, which holds the largest market share. This dominance is primarily driven by the high unmet medical needs in cancer treatment and substantial investments by governments and private sectors worldwide in oncology research and development. Cancer continues to be a leading cause of death globally, prompting initiatives such as the U.S. National Cancer Institute’s increased funding for precision medicine and targeted therapies. DNA-encoded libraries accelerate the identification of novel small molecules that target specific cancer-related proteins or pathways, enabling faster development of personalized and more effective cancer treatments. Government programs promoting innovation in drug discovery further bolster the adoption of DEL technologies in oncology.
Neurological diseases represent the fastest-growing segment within the global DEL market. This growth is fueled by the rising incidence of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and other central nervous system (CNS) conditions, which pose significant public health challenges worldwide. Governments, including the European Union through initiatives like the Joint Programme on Neurodegenerative Disease Research (JPND), are increasing funding to overcome the barriers in CNS drug discovery, including the challenge of crossing the blood-brain barrier. DEL technology facilitates the high-throughput screening of vast chemical libraries against these complex neurological targets, providing promising pathways to develop treatments for diseases that have historically lacked effective options.
When segmented by application, the hit generation or hit identification phase accounts for the largest share of the global DNA-encoded library market. This reflects DEL’s core capability to rapidly screen billions of compounds against biological targets to discover initial hits with strong binding affinities. Governments globally recognize the importance of accelerating drug discovery processes; for example, initiatives like the U.S. FDA’s Critical Path Initiative encourage the adoption of innovative technologies that improve efficiency and reduce time-to-market for new therapeutics. By streamlining early-stage drug discovery, DEL technologies help researchers expedite the development of novel treatments, addressing urgent public health needs more effectively.
The fastest-growing application segment in the DEL market is hit to lead optimization. This phase has gained momentum due to the increasing complexity of modern drug discovery pipelines and the recognition that identifying initial hits is only the first step—rapid optimization of these hits into potent, drug-like lead compounds is essential. Innovations in on-DNA chemistry are enabling the creation of more complex and therapeutically viable molecules, supported by government research grants focused on advanced drug design and medicinal chemistry. Such efforts align with broader public health goals of delivering safer and more effective drugs to patients in shorter timeframes.
DNA-Encoded Library Market- Geographical Insights
North America currently leads the DNA-Encoded Library (DEL) market, driven by a well-established pharmaceutical and biotechnology sector supported by substantial investments from major corporations and the emergence of innovative smaller firms. The United States, in particular, is experiencing rapid growth, bolstered by increased government research funding—accounting for over 40% of global pharmaceutical R&D investment—strong intellectual property protections, and widespread adoption of cutting-edge technologies for drug discovery. The active participation of numerous academic and research institutions, along with a robust network of contract research organizations (CROs), further fosters the development and utilization of advanced DEL services in the region.
Meanwhile, Asia-Pacific is the fastest-growing region in the DEL market. This growth is fueled by significant R&D investments from various companies, the rapid expansion of the biotechnology sector, and an increasing focus on drug manufacturing and research. Additionally, a large skilled workforce and a thriving CRO industry adopting DEL technology are key factors propelling market expansion. China, Japan, and India stand out as major contributors to the region’s development, supported by government initiatives that, collectively, have allocated billions of dollars globally towards innovative drug discovery platforms in recent years.
DNA-Encoded Library Market- Competitive Landscape:
Key players in the DNA-Encoded Library (DEL) market include providers of DEL technology, leading biopharmaceutical and biotechnology companies, and contract research organizations (CROs) offering DEL screening services. These companies differentiate themselves through the size and diversity of their libraries, innovative on-DNA chemistry techniques, customized screening processes, and comprehensive drug discovery solutions. Strong collaborations between technology providers and pharmaceutical clients are accelerating the identification of promising drug candidates across various therapeutic areas. Significant efforts are underway to enhance library functionality, increase screening speed, and integrate artificial intelligence (AI) and machine learning (ML) with DEL technology to improve the identification of valuable compounds. The competitive nature of the DEL market fosters innovation, leading to advanced and more accessible DEL platforms that benefit the broader drug discovery industry.
Recent Developments:
- September 2024: Life Chemicals partnered with Variational AI to develop and screen novel target-selective molecule libraries. Leveraging AI, this collaboration aims to generate new compounds targeting key kinase and GPCR proteins. Their first offering is the EGFR AI-Created Screening Compound Library, featuring over 2,500 compounds.
- September 2024: Charles River Laboratories and Valo Health discovered a novel drug candidate for lupus using Logica®, an AI-powered drug discovery tool. This achievement highlights how Logica® accelerates and enhances drug discovery by combining Valo’s DNA libraries and Opal Platform with Charles River’s expertise.
- June 2024: SPT Labtech and Watchmaker Genomics collaborated to simplify and speed up next-generation sequencing (NGS) library preparation. While not specifically designed for DEL, SPT Labtech’s automated liquid handling instruments play a critical role in DEL workflows, showcasing advances in laboratory technology.
- February 2024: Aurigene Pharmaceutical Services Limited announced a partnership with Edity Therapeutics Limited to advance cell therapy development, reflecting their ongoing commitment to expanding discovery services. As a partner of Vipergen, Aurigene offers DEL screening services that complement their integrated drug discovery approaches.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DNA-ENCODED LIBRARY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Merck KGaA
- GenScript
- Pharmaron
- WuXi Biology
- Aurigene Pharmaceutical Services
- BOC Sciences
- LGC Bioresearch Technologies
- SPT Labtech Ltd
- Life Chemicals
- Charles River Laboratories
GLOBAL DNA-ENCODED LIBRARY MARKET, BY THERAPEUTIC AREA - MARKET ANALYSIS, 2019 - 2032
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Diseases
- Autoimmune Diseases
- Metabolic Diseases
- Others
GLOBAL DNA-ENCODED LIBRARY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hit Generation / Identification
- Hit to Lead
- Hit Validation / Optimization
- Others
GLOBAL DNA-ENCODED LIBRARY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
GLOBAL DNA-ENCODED LIBRARY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. DNA-Encoded Library Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. DNA-Encoded Library Market Snippet By Therapeutic Area
2.1.2. DNA-Encoded Library Market Snippet by Application
2.1.3. DNA-Encoded Library Market Snippet By End User
2.1.4. DNA-Encoded Library Market Snippet by Country
2.1.5. DNA-Encoded Library Market Snippet by Region
2.2. Competitive Insights
3. DNA-Encoded Library Key Market Trends
3.1. DNA-Encoded Library Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. DNA-Encoded Library Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. DNA-Encoded Library Market Opportunities
3.4. DNA-Encoded Library Market Future Trends
4. DNA-Encoded Library Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. DNA-Encoded Library Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. DNA-Encoded Library Market Landscape
6.1. DNA-Encoded Library Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. DNA-Encoded Library Market – By Therapeutic Area
7.1. Overview
7.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
7.1.2. Oncology
7.1.3. Infectious Diseases
7.1.4. Cardiovascular Diseases
7.1.5. Neurological Diseases
7.1.6. Autoimmune Diseases
7.1.7. Metabolic Diseases
7.1.8. Others
8. DNA-Encoded Library Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Hit Generation / Identification
8.1.3. Hit to Lead
8.1.4. Hit Validation / Optimization
8.1.5. Others
9. DNA-Encoded Library Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Academic & Research Institutes
9.1.3. Pharmaceutical & Biotechnology Companies
9.1.4. Contract Research Organizations
9.1.5. Others
10. DNA-Encoded Library Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. DNA-Encoded Library Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. DNA-Encoded Library Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. DNA-Encoded Library Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. DNA-Encoded Library Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. DNA-Encoded Library Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- DNA-Encoded Library Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Merck KGaA
11.2.2. GenScript
11.2.3. Pharmaron
11.2.4. WuXi Biology
11.2.5. Aurigene Pharmaceutical Services
11.2.6. BOC Sciences
11.2.7. LGC Bioresearch Technologies
11.2.8. SPT Labtech Ltd
11.2.9. Life Chemicals
11.2.10. Charles River Laboratories
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
